Baxter International (Baxter International) Additional Paid-In Capital : $6,339 Mil(As of Mar. 2024)

View and export this data going back to 1961. Start your Free Trial

What is Baxter International Additional Paid-In Capital?

Baxter International's quarterly additional paid-in capital increased from Sep. 2023 ($6,368 Mil) to Dec. 2023 ($6,389 Mil) but then stayed the same from Dec. 2023 ($6,389 Mil) to Mar. 2024 ($6,339 Mil).

Baxter International's annual additional paid-in capital increased from Dec. 2021 ($6,197 Mil) to Dec. 2022 ($6,322 Mil) and increased from Dec. 2022 ($6,322 Mil) to Dec. 2023 ($6,389 Mil).

Baxter International Additional Paid-In Capital Historical Data

The historical data trend for Baxter International's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baxter International Additional Paid-In Capital Chart

Baxter International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

5,955.00

6,043.00

6,197.00

6,322.00

6,389.00

Baxter International Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															6,312.00	6,341.00	6,368.00	6,389.00	6,339.00

Baxter International Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Baxter International Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Baxter International's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Baxter International (Baxter International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baxter International Inc (NYSE:BAX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

1BAX:Italy BTL:Germany BTL:Germany BTL:Germany BAX:Austria

Address

One Baxter Parkway, Deerfield, IL, USA, 60015

Website

https://www.baxter.com

Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment, including hospital beds, to the portfolio, although about half of Hillrom's revenue comes from more digitally connected offerings like its smart beds and Voalte medical communications app. From its legacy operations, Baxter offers tools to help patients with acute and chronic kidney failure, which it plans to spin off by mid-2024. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents.

Executives

Joel T. Grade	officer: EVP, Chief Financial Officer	SYSCO CORPORATION, 1390 ENCLAVE PARKWAY, HOUSTON TX 77077
Stephen H Rusckowski	director	C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Ampofo William A. Ii	director	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Christopher A. Toth	officer: EVP, Group Pres, Kidney Care	1252 COOLIDGE AVE., SAN JOSE CA 95125
Stroucken Albert P L	director	BAXTER INTERNATIONAL INC., ONE BAXTER PARKWAY, DEERFIELD IL 60015
Reaz Rasul	officer: EVP, Group Pres, Healthcare	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Alok Sonig	officer: EVP, Group President, Pharm	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Heather Knight	officer: EVP, Group Pres, Medical	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jacqueline Kunzler	officer: SVP, Chief Quality Officer	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Jeanne K Mason	officer: CVP, Human Resources	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Steven Flynn	officer: SVP, President, APAC	ONE BAXTER PARKWAY, DEERFIELD IL 60015
Peter M Wilver	director
David Brent Shafer	director	2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Amy Mcbride Wendell	director	COVIDIEN LTD., 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Cathy R Smith	director	TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403